Accesswire
04 May 2026, 05:50 UTC · 26w ago
Verdict
Headline takes no side. We score EVO +1.00 — strongly bullish.
+1.00strongly bullish
More positive than 98% of ticker scores this week
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
More positive than 79% of relationship scores this week
[mutual] Evotec and Almirall are in a multi-target drug discovery alliance for medical dermatology.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Newsfile Corp
32m ago
—
No price for EVO right now — the quote feed didn't answer.
EVO chart →
